Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Westlake Chemical Partners (WLKP) EBT (2016 - 2025)

Historic EBT for Westlake Chemical Partners (WLKP) over the last 13 years, with Q3 2025 value amounting to $86.3 million.

  • Westlake Chemical Partners' EBT fell 1731.28% to $86.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $302.3 million, marking a year-over-year decrease of 1823.45%. This contributed to the annual value of $370.0 million for FY2024, which is 1030.14% up from last year.
  • As of Q3 2025, Westlake Chemical Partners' EBT stood at $86.3 million, which was down 1731.28% from $86.0 million recorded in Q2 2025.
  • In the past 5 years, Westlake Chemical Partners' EBT registered a high of $138.6 million during Q4 2021, and its lowest value of $42.4 million during Q1 2025.
  • For the 5-year period, Westlake Chemical Partners' EBT averaged around $87.3 million, with its median value being $86.3 million (2025).
  • In the last 5 years, Westlake Chemical Partners' EBT surged by 8412.59% in 2021 and then crashed by 5279.56% in 2025.
  • Quarter analysis of 5 years shows Westlake Chemical Partners' EBT stood at $138.6 million in 2021, then plummeted by 34.02% to $91.5 million in 2022, then fell by 4.58% to $87.3 million in 2023, then rose by 0.37% to $87.6 million in 2024, then decreased by 1.52% to $86.3 million in 2025.
  • Its EBT stands at $86.3 million for Q3 2025, versus $86.0 million for Q2 2025 and $42.4 million for Q1 2025.